Dan Benjamin Teleman - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Dan Benjamin Teleman has filed 2 SEC Form 4 filings across 1 company in the last 90 days - buying. Lifetime open-market purchases: $62K.
Profile
Dan Benjamin Teleman is the Chief Executive Officer at Nasus Pharma Ltd (NSRX). Teleman has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 40/100 |
Board memberships
- Nasus Pharma Ltd
Reported roles
- Chief Executive Officer
Awards & honors
- Leadership in pharmaceutical innovation
Trading Pattern
InsiderAlpha's records for Dan Benjamin Teleman go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $21K (3 buys totaling $62K). The largest single buy on record is $31K of NSRX in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Dan Benjamin Teleman has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Executive Officer, Director at Nasus Pharma Ltd (NSRX) - 4 filings, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | NSRX | Nasus Pharma Ltd | P - Open-market purchase | 6.5K | $3.10 | $20K |
| 2026-04-23 | NSRX | Nasus Pharma Ltd | P - Open-market purchase | 2.9K | $3.76 | $11K |
| 2026-04-01 | NSRX | Nasus Pharma Ltd | P - Open-market purchase | 15.0K | $2.04 | $31K |
Companies - Last 90 Days
- Nasus Pharma Ltd (NSRX) - 2 filings, last 2026-07-29
Most Active Insiders Right Now
Dan Benjamin Teleman has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Kenneth Bryan Dart
- Charles A. Davis
- Deep Track Biotechnology Master Fund, Ltd.
- Robert E. Dixon
- Romeo R. Dizon
- DONEGAL MUTUAL INSURANCE CO
- DORCHESTER MINERALS OPERATING LP
- Robert W. Duggan
Frequently Asked Questions
Who is Dan Benjamin Teleman?
Dan Benjamin Teleman is the Chief Executive Officer at Nasus Pharma Ltd (NSRX). Teleman has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Dan Benjamin Teleman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Dan Benjamin Teleman been buying or selling stock?
Recorded transactions: 3 open-market purchases ($62K) and 0 open-market sales across all tracked filings.
Where can I see all of Dan Benjamin Teleman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Dan Benjamin Teleman profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.